Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Approval for pediatric extension of Fludara

Aug. 26, 2003

Approvable letter for Zometa for patients with bone metastases from advanced cancer

Aug. 26, 2003

Effect of DN-101 on chemotherapy for NSCLC evaluated in new phase I/II trial

Aug. 26, 2003

Cytochroma discovers new retinoic acid metabolizing cytochrome P450

Aug. 26, 2003

Good toxicity profile reported for squalamine in patients with solid tumors

Aug. 26, 2003

Local methotrexate reported to inhibit tumor progression in mice

Aug. 26, 2003

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Aug. 25, 2003

Thalidomide recommended for approval in Australia

Aug. 25, 2003

Phase I bridging study of LEP-ETU commences

Aug. 25, 2003

IND filed for Atrigel formulation of octreotide

Aug. 25, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...